Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist.
Katherine L Hull, Sherna F Adenwalla, Peter Topham...
https://pubmed.ncbi.nlm.nih.gov/34921054/Actively Recruiting
Led by Centre Hospitalier William Morey - Chalon sur Saône · Updated on 2026-03-18
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
This research aims to assess the use of dynamic full-field optical coherence tomography for analyzing kidney biopsies in patients suspected of having acute kidney injury or chronic kidney disease. Kidney biopsies remain crucial for accurate diagnosis, prognosis, and treatment decisions despite being invasive and carrying potential risks. The study evaluates whether this imaging method can improve the speed and quality of histopathological examination compared to conventional techniques. Participants in this observational study will undergo dynamic full-field optical coherence tomography analysis of their kidney biopsy samples in the nephrology department before the usual histopathological analysis. This approach is being assessed in routine clinical practice among patients aged 18 and older who require a kidney biopsy due to suspected kidney injury or disease. Throughout the study, researchers will measure the histopathological features of kidney tissue using this imaging technique at 15 days following biopsy. They will also evaluate its performance on healthy kidney tissue samples. The study will monitor how well this method identifies elementary lesions and its potential role in routine diagnostic workflows. Participant involvement includes the biopsy procedure and subsequent tissue analysis, with no additional treatments or interventions involved.
CONDITIONS
Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT)
T
Thomas Maldiney
Q
Quentin Bernard
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre Hospitalier William Morey - Chalon sur Saône
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 15 days
Participants undergo dynamic full-field optical coherence tomography analysis of kidney biopsy before conventional histopathological analysis to diagnose acute kidney injury or chronic kidney disease.
1 biopsy procedure visit
Duration - Approximately 15 days
Participants are monitored following the biopsy and diagnostic evaluation to assess histopathological outcomes.
Follow-up assessments as part of routine care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Katherine L Hull, Sherna F Adenwalla, Peter Topham...
https://pubmed.ncbi.nlm.nih.gov/34921054/Manu Jain, Brian D Robinson, Bekheit Salamoon...
https://pubmed.ncbi.nlm.nih.gov/26605118/Centre Hospitalier William Morey - Chalon sur Saône
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Collaborating Sponsor